Testing effectiveness (Phase 2)Looking for participantsNCT07055581What this trial is testingDurvalumab as Consolidation for Patients LS-SCLCWho this might be right forSmall Cell Lung Cancer Limited Stage Qian Chu 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07589699What this trial is testingTrastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHPWho this might be right forBreast CancerHER2-positive Breast CancerEarly-stage Breast Cancer+1 more The First Affiliated Hospital with Nanjing Medical University 59
Testing effectiveness (Phase 2)Looking for participantsNCT07380984What this trial is testingPD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCLWho this might be right forNatural Killer/T-cell Lymphoma Ruijin Hospital 47
Not applicableActive Not RecruitingNCT06387173What this trial is testingRegistry of Patients Undergoing Cryoablation for Early Stage Breast CancerWho this might be right forEarly Stage Breast Carcinoma Jonsson Comprehensive Cancer Center 2
Large-scale testing (Phase 3)Study completedNCT00009945What this trial is testingClodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast CancerWho this might be right forBreast Cancer NSABP Foundation Inc 3,323
Testing effectiveness (Phase 2)Temporarily pausedNCT06694454What this trial is testingNeoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small Cell LungNon-Small Cell Lung Carcinoma+2 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT01165021What this trial is testingPemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Eli Lilly and Company 19
Testing effectiveness (Phase 2)Looking for participantsNCT07508852What this trial is testing68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung CancerWho this might be right forSCLCSCLC, Extensive StageSCLC, Limited Stage+2 more Peking University First Hospital 30
Not applicableStudy completedNCT05278533What this trial is testingEvaluate the Use of the Foundation Pain Index and the Nutritional Supplement BioPlete™ in Adults With Chronic PainWho this might be right forChronic Pain Ethos Research & Development 30
Testing effectiveness (Phase 2)Study completedNCT04877821What this trial is testingThe Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBCWho this might be right forTriple Negative Breast Cancer Guangdong Provincial People's Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT07594522What this trial is testingIvonescimab in People With Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 36
Large-scale testing (Phase 3)UnknownNCT05673629What this trial is testingUtidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast CancerWho this might be right forBreast Cancer Beijing Biostar Pharmaceuticals Co., Ltd. 552
Not applicableLooking for participantsNCT04902937What this trial is testingAssociation of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.Who this might be right forTumor Cell, Circulating University of Jena 200
Large-scale testing (Phase 3)Study completedNCT00493870What this trial is testingTAC Versus TC for Adjuvant Breast CancerWho this might be right forBreast Cancer US Oncology Research 1,961
Testing effectiveness (Phase 2)Active Not RecruitingNCT05558722What this trial is testingAnlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast CancerWho this might be right forBreast Cancer Stage II Xijing Hospital 31
Testing effectiveness (Phase 2)Ended earlyNCT00214149What this trial is testingMulti-catheter High Dose Rate (HDR) Breast BrachytherapyWho this might be right forBreast Cancer University of Wisconsin, Madison 127
Not applicableLooking for participantsNCT04458532What this trial is testingExercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast CancerWho this might be right forEarly Stage Breast Cancer Memorial Sloan Kettering Cancer Center 152
Not applicableStudy completedNCT07629063What this trial is testingEffectiveness of Resistance Exercises Added to Aerobic and Balance Exercises in Parkinson's DiseaseWho this might be right forParkinson's Disease (PD)Sarcopenia Sisli Hamidiye Etfal Training and Research Hospital 34
Not applicableLooking for participantsNCT07168993What this trial is testingEvaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.Who this might be right forLung Cancer (Diagnosis) bioAffinity Technologies Inc. 2,063
Not applicableNot Yet RecruitingNCT06943911What this trial is testingReflects the Intervention (AI Chatbot)Who this might be right forBreast Cancer Early Stage Breast Cancer (Stage 1-3) Mostafa Shaban 122